Fund profile / France

Kurma Partners Biofund IV

Geography: France
Stage: Series A
Fund size: €215M
Focus: Biotech and Therapeutics
Signals: Published

N°01 / About

About Kurma Partners Biofund IV

Kurma Partners closes €215M Biofund IV, crossing €1B AUM on back of four big pharma exits. Invests in European biotech and biopharma companies at Series A and B stages.

N°02 / Thesis

Investment Focus

Location / RegionFrance

Funding StageSeries A

Industry Focus

Biotech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Scientific founder or academic researcher in European therapeutics targeting severe or rare disease

biotech-early-stage

company-creation

rare-disease

therapeutics

academic-spinouts

Bullish Signals

Four Big Pharma exits in single fund cycle — AZ, Lilly, uniQure, Ipsenblog

CSL cornerstone LP signals privileged pharma BD access for portfolio companiesblog

11 investments already made, 9 more planned with capital actively deployingblog

Crossed €1B AUM enabling co-lead roles on larger European roundsblog

Paris HQ — 24 Rue Royale, prime location confirmedlinkedin

Website active — kurmapartners.com operationallinkedin

Fund classified as VC and Private Equity dual-thesis operatorexternal

11-50 staff headcount maintains lean, high-conviction investment modelfresh_scrape

Financial Services sector classification confirmed operational stabilityexternal

Contrarian Signals

Fund closed €35M below €250M target — LP appetite had limitsblog

Company-creation model is slower — 10-12 year timeline to exitblog

80% therapeutics concentration creates binary clinical outcome riskblog

Founder Do's

Engage Kurma before forming a legal entity if you have academic IP

Focus pitch on severe or rare diseases with high unmet medical need

Highlight scientific depth and academic institution partnerships

Demonstrate readiness for long-term pharma BD conversations

Position your program for eventual Big Pharma trade sale

Founder Don'ts

Pitch non-therapeutic plays — 80% focus is therapeutics only

Expect purely financial partnership — they are deeply hands-on operationally

Come without strong scientific credentials or life sciences background

24 signals on Kurma Partners Biofund IV

9 bullish · 3 contrarian · 5 pitch do's · 3 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€215M

Saves0

Website

People

Key People

Vanessa Malier

Jacques ChatainDirecteur Général / Founder

Jim CowartManaging Partner

Hadrien BouchezPartner

Daniel PareraPrincipal

Backers

Known LPs

European Investment Fund (EIF)Fund-of-Funds

BpifrancePublic / State institution

CSL LimitedCorporate / Strategic

+1 more LP in LP Radar

N°04 / See also

Related Funds

Clover Fund I

Fund size€30M

Location: France
Stage: Pre Seed
Focus: Ai Ml, Digital Education Consumer, Saas
Manager: Samuel Tual

Pre Seed

Ai Ml

Digital Education Consumer

Saas

BNP Paribas Solar Impulse Venture Fund

Fund size€172M

Location: France
Stage: Pre Seed
Focus: Climate Sustainability, Mobility Transport, Saas
Manager: Yann Lagalaye

Pre Seed

Climate Sustainability

Mobility Transport

Saas

Axeleo Capital (AXC)

Fund size€125M

Location: France
Stage: Pre Seed
Focus: Saas
Manager: Eric Burdier

Pre Seed

Saas